Recipharm AB has entered into a strategic collaboration with Alcon, a Novartis company, and a long-term supply agreement to manufacture a range of ophthalmic products using Blow Fill Seal technology. Additionally, Recipharm will acquire Alcon’s Kaysersberg Pharmaceuticals for €18 million, gaining its manufacturing facility in Kaysersberg, France, which currently supplies this product range.   The long term manufacturing agreement is expected to add annual sales of more than €36 million and ext...